UCSF-Gladstone CFAR Presentations and Posters: 2015 IAS Meeting

IAS Logo

UCSF-Gladstone CFAR-supported investigators had a major presence at the 2015 IAS meeting in Vancouver, Canada this year. See the IAS Abstract Book for details.

  1. Asmuth D, Somsouk M, Hunt P, Ma ZM, Miller C, Li XD, Hinkle J, Shaw A, Weaver E, Klein G. Serum-derived bovine immunoglobulin isolate increases peripheral and mucosal CD4 T cell count in patients with HIV enteropathy. Abstract MOAA0204. Video: https://youtu.be/bKoGJ-2u338.
  2. Blanco-Heredia J, Avila-Rios S, Nixon DF, Reyes Terán G, Raposo RA. Decreased interferon signature in HIV-1 viremic controllers. Abstract WEPEA109.
  3. Buzdugan R, McCoy SI, Watadzaushe C, Kang Dufour M-S, Petersen M, Dirawo J, Mushavi A, Mujuru HA, Mahomva A, Engelsmann B, Hakobyan A, Mugurungi O, Cowan FM, Padian NS. Zimbabwe approaching virtual elimination of mother to child transmission of HIV following implementation of Option A. Abstract MOAC0203.
  4. Camlin CS, Ssemmondo E, Chamie G, Kwarisiima D, Sang N, Bukus EA, Cohen CR, Kamya MR, Havlir D. Men “missing” from population-based HIV testing: insights from qualitative research. Abstract TUPDD0102.
  5. Chang C, Cameron P, Elliott J, Perelson A, Roche M, Dantanarayana A, Solomon A, Naranbhai V, Tenakoon S, Hoh R, McMahon J, Sikaris K, Hartogensis W, Bacchetti P, Hecht F, Lifson J, Deeks S, Lewin S. Time associated changes in cell-associated HIV RNA in HIV-infected subjects on suppressive antiretroviral therapy - implications for clinical trials of cure interventions. Abstract MOAA0106LB.
  6. Chemnasiri T, Varangrat A, Amico KR, Chaikummao S, Chitwarakorn A, Dye BJ, Grant RM, Holtz TH, HPTN 067/ADAPT Study Team. Facilitators and barriers affecting PrEP adherence among Thai men who have sex with men in the HPTN 067/ADAPT study, a qualitative analysis. Abstract WELBPE23.
  7. Chew G, Fujita T, Clayton K, Ishii N, Abdel-Mohsen M, Liegler T, Hecht F, Ostrowski M, Shikuma C, Maurer M, Korman A, Deeks S, Ndhlovu L. Investigating the role of the immune checkpoint receptor TIGIT in T cells during HIV disease progression and as a target for immune restoration. Abstract TUAA0204LB.
  8. Cohen M, Chen Y, McCauley M, Gamble T, Hosseinipour M, Kumarasamy N, Hakim J, Kumwenda N, Brum T, Grinsztejn B, Godbole S, Chariyalertsak S, Riegel Santos B, Mayer K, Hoffman I, Eshleman S, Piwowar-Manning E, Ou S-S, Cottle L, Makhema J, Mills L, Panchia R, Badal-Faesen S, Eron J, Gallant J, Havlir D, Swindells S, Elharrar V, Burns D, Taha T, Nielsen K, Celentano D, Essex M, Fleming T; HPTN 052 Study Group. Final results of the HPTN 052 randomized controlled trial: antiretroviral therapy prevents HIV transmission. Abstract MOAC0101LB.
  9. Demarco T, Rountree W, Hora B, Chen Y, Keinonen S, Racz L, Daniell L, Louzao R, Sanchez A, Busch M, Denny T, Gao F. HIV-1 subtype C is significantly more infectious than other subtypes. Abstract WEPDA0103.
  10. Franks J, Hirsch-Moverman Y, Loquere A, Amico KR, Dye BJ, Mckinstry L, Grant RM, Mannheimer S. PrEP, sex, and the paradoxes of prevention: qualitative data from New York City participants in HPTN 067. Abstract TULBPE21.
  11. Fromentin R, Ramirez CM, Khoury G, Sinclair E, Hecht FM, Deeks SG, Sekaly RP, Lewin SR, Chomont N. Immunological markers associated with HIV persistence during ART identified by iterated conditional random forests analysis. Abstract WEPEA135.
  12. Galagan S, Gilyvdis JM, Lippman SA, Grignon J, Shade S, Naidoo E, Raphela E, Tumbo J, Barnhart S, Kohler PK. Loss of HIV-positive patients in rural primary health care facilities in North West province, South Africa: a retrospective register audit. Abstract MOPED738.
  13. Gangcuangco LM, Chow D, Keating S, Norris P, Nagamine L, Ndhlovu L, Kallianpur K, Shikuma C. Higher 25-hydroxyvitamin D is associated with higher levels of plasma soluble biomarkers in older HIV-infected patients on stable antiretroviral therapy. Abstract WEPEB343.
  14. Ghneim K, Ahlers J, Fourati S, Shive C, Cameron M, Mukerjee P, Ghannoum M, Rodriguez B, Deeks S, Lederman M, Sekaly R. Trancriptomics and metabolomics identify inflammatory profiles that segregate subjects with high and low inducible HIV reservoir. Abstract MOAA0104.
  15. Gianella Weibel S, Ginocchio CC, Smith DM, Daar ES, Dube MP, Haubrich RH, Morris SR, CCTG Study Group. Genital shedding of Epstein Barr virus (EBV) is associated with higher prevalence and persistence of anal human papilloma virus (HPV) in HIV-infected men on antiretroviral therapy (ART). Abstract WEPEB319.
  16. Gianella Weibel S, Redd AD, Grabowski MK, Tobian AAR, Serwadda D, Newell K, Patel EU, Kalibbala S, Ssebbowa P, Gray RH, Quinn TC, Reynolds SJ. Vaginal cytomegalovirus shedding before and after initiation of antiretroviral therapy in Rakai, Uganda. Abstract MOPEB174.
  17. Gottert S, Barrington C, McNaughton-Reyes HL, Maman S, MacPhail C, Lippman SA, Kahn K, Twine R, Pettifor A. Gender norms, masculine gender-role strain and HIV risk behaviors among men in rural South Africa. Abstract MOPEC477.
  18. Greener RM, Milford C, Mosery FN, Bajunirwe F, Pillay L, Moore L, Ng C, Kastner J, Rifkin R, Smit JA, Bangsberg DR, Kaida A, Matthews LT. Healthcare providers’ understanding of HIV sero-discordance in South Africa and Uganda: implications for HIV prevention counselling. Abstract TUPEC572.
  19. Haleyur Giri Setty MK, Panhe Z, Liu J, Du B, Keating SM, Busch MP, Pilcher C, Cohen M, Haynes BF, Vermeulen M, Hewlett IK. Novel diagnostic peptide epitope biomarkers for detection and identification of recent and longstanding HIV infection using the Europium Nanoparticle Immuno Assay (ENIA). Abstract TUPEB218.
  20. Han L, Tang W, Best J, Zhang Y, Kim J, Liu F, Mollan K, Hudgens M, Bayus B, Terris-Prestholt F, Galler S, Yang L, Peeling R, Volberding P, Ma B, Yang B, Huang S, Fenton K, Wei C, Tucker J. Crowdsourcing to spur first-time HIV testing among men who have sex with men and transgender individuals in China: a non-inferiority pragmatic randomized controlled trial. Abstract TUAD0104.
  21. Heffron R, Thomson K, Celum C, Mugo N, Katabira E, Bukusi E, Asiimwe S, Ngure K, Bulya N, Odoyo J, Tindimwebwa E, Donnell D, Baeten J; The Partners Demonstration Project Team. Fertility intentions, pregnancy and PrEP use in African HIV serodiscordant couples. Abstract TUPEC511.
  22. Hojilla JC, Mehrotra M, Mcmahan V, Bekker L-G, Guanira JV, Hoagland B, Hosek S, Amico KR, Glidden D, Grant R, iPrEx Study Team. Individual and sexual network characteristics are associated with HIV serodisclosure in the global iPrEx study. Abstract TUPEC520.
  23. Helova A, Akama E, Bukusi E, Musoke P, Nalwa W, Odeny T, Onono M, Turan JM, Wanga I, Abuogi L. Health facility challenges to the provision of Option B+ in Kenya. Abstract WEPED869.
  24. Holtz TH, Chitwarakorn A, Curlin ME, Hughes J, Amico KR, Hendrix C, Dye BJ, Anderson PL, Ou S-S, Elharrar V, Eshleman SH, Stirratt M, Grant RM; Bangkok HPTN 067/ADAPT Study Team. HPTN 067/ADAPT study: a comparison of daily and non-daily pre-exposure prophylaxis dosing in Thai men who have sex with men, Bangkok, Thailand. Abstract MOAC0306LB.
  25. Hora B, Keating S, Chen Y, Sanchez AM, Sabino E, Hunt G, Hackett Jr J, Swanson P, Hewlett I, Ragupathy V, Vemula SV, Zeng P, Tee K-K, Chow WZ, Denny TN, Busch MP, Gao F. Genetic characterization of a large panel of diverse HIV-1 strains at six international sites. Abstract WEPEC640.
  26. Kabami J, Kwarisiima D, Chamie G, Biira E, Ssebutinde P, Petersen M, Charlebois ED, Kamya MR, Havlir DV, Clark TD. A community-led health campaign in a low-resource rural setting in Western Uganda. Abstract TUPED793.
  27. Karn J, Das B, Dobrowolski C, Scully E, Deeks S, Gandhi M, Johnston R. Estrogen blocks HIV re-emergence from latency and points to gender-specific differences in HIV reservoirs. Abstract TUAA0205LB. Video: https://youtu.be/89F8APQRQwU.
  28. Kinloch NN, Macmillan DR, Le AQ, Cotton LA, Mccloskey R, Bangsberg DR, Buchbinder S, Carrington M, Fuchs J, Harrigan PR, Koblin B, Markowitz M, Mayer K, Milloy MJ, Schechter MT, Wagner T, Walker BD, Carlson JM, Poon AFY, Brumme ZL. Population-level spread of immune-driven mutations in HIV-1 polymerase during the North American epidemic. Abstract TUAA0103. Video: https://youtu.be/12aYFCR2SAQ
  29. Körner C, Simoneau CR, Granoff M, Corleis B, Scully E, Kwon DS, Jost S, Altfeld M. NK cells expressing self-inhibitory KIR2DL receptors exhibit a reduced capacity to inhibit HIV-1 replication in vitro. Abstract WEPEA117.
  30. Lee E, Hiener B, Bacchetti P, Shao W, Boritz E, Douek D, Somsouk M, Hunt P, Fromentin R, Deeks SG, Hecht FM, Chomont N, Palmer S. Distinct HIV genetic populations in effector memory T cells after prolonged therapy. Abstract WEPEA138.
  31. Lee GQ, Bangsberg DR, Lachowski C, Brumme CJ, Boum Y, Mocello AR, Kigozi SH, Hunt PW, Martin JN, Harrigan PR. Prevalence and clinical impacts of HIV-1 intersubtype recombinants in Uganda. Abstract MOPEA040.
  32. Lee S, Chomont N, Fromentin R, Silicano R, Silicano J, Richman D, O'Doherty U, Palmer S, Burbelo P, Deeks S. Anti-HIV antibody responses reflect the quantifiable HIV reservoir size. Abstract MOAA0103.
  33. Lightfoot M, Bennett A, Jackson-Morgan J, Pollack L. Effectiveness of text messaging to increase adolescent engagement in prevention. Abstract MOPEC433.
  34. Lippman SA, Moran ME, Ventura A, Castillo LS, Buchbinder S, Treves-Kagan S, Sevelius JM. Home HIV testing among transgender women in San Francisco: a pilot feasibility and acceptability study, Abstract MOPDC0104.
  35. Lippman SA, Pettifor AP, Neilands TB, MacPhail C, Peacock D, Maman S, Twine R, Selin A, Kahn K. Communities can mobilize to test: findings from a community randomized trial of a theory-based community mobilization (CM) intervention in South Africa. Abstract MOPDC0101
  36. Lippman SA, Shade SB, Gilvydis JM, El Ayadi AM, Naidoo E, Morris J, Prach LM, Grignon JS, Puren A, Liegler T, Barnhart S. Characterizing the continuum of care in a population-based sample to target programming in North West Province, South Africa. Abstract WEPEC665.
  37. Liu A, Cohen S, Vittinghoff E, Anderson P, Doblecki-Lewis S, Bacon O, Chege W, Elion R, Buchbinder S, Kolber M; Demo Project Study Group. Adherence, sexual behavior and HIV/STI incidence among men who have sex with men (MSM) and transgender women (TGW) in the U.S. PrEP demonstration (Demo) project. Abstract TUAC0202. Video: https://youtu.be/6SP3Hbe27lM.
  38. Ludema C, Cole SR, Eron Jr JJ, Edmonds A, Holmes GM, Anastos K, Cocohoba J, Cohen MH, Cooper H, Golub ET, Kassaye S, Konkle-Parker D, Metsch L, Milam J, Wilson TE, Adimora AA. Health insurance, ADAP and HIV viral load among women in the Women’s Interagency HIV study, 2006-2009. Abstract WEPEC613.
  39. Mannheimer S, Hirsch-Moverman Y, Loquere A, Franks J, Hughes J, Ou S-S, Amico KR, Hendrix C, Dye BJ, Piwowar-Manning E, Marzinke M, Elharrar V, Stirratt M, Grant RM; HPTN 067/ADAPT Harlem Study Team HPTN 067/ADAPT study: a comparison of daily and intermittent pre-exposure prophylaxis (PrEP) dosing for HIV prevention in men who have sex with men and transgender women in New York city. Abstract MOAC0305LB.
  40. Matthews LT, Ashaba S, Psaros C, Burns BF, Dunkley E, Kastner J, Tsai AC, Robak M, Haberer JE, Hunt PW, Martin JN, Boum Y, Bangsberg DR, Kaida A. From option A to B+: exploring challenges of navigating evolving PMTCT strategies among postpartum women living with HIV in rural Uganda. Abstract MOPEB188.
  41. McCoy SI, Buzdugan R, Kang Dufour M, Musarandega R, Mushavi A, Mahomva A, Engelsmann B, Padian NS, Cowan FM. Dramatic improvements in uptake of prevention of mother to child HIV transmission services in Zimbabwe, 2012-2014. Abstract MOPEC458.
  42. Mirzazadeh A, Evans J, Jain J, Hahn J, Shiboski S, Bentsen C, Shriver K, Dimpasoc M, Stone M, Busch MP, Page K. HIV incidence is low and stable in young adults who inject drugs in San Francisco: UFO study 2000-2014. Abstract WEPEC605.
  43. Musoke P, Wanga I, Turan J, Onono M, Nalwa W, Helova A, Bukusi E, Akama E, Abuogi L, Odeny T. Using text messaging to maximize adherence and retention for women and infants in the context of Option B+ in Kenya. Abstract WEPED870.
  44. Ngure K, Heffron R, Hong T, Mugo N, Bukusi E, Ndase P, Mujugira A, Muwonge T, Celum C, Baeten JM. Discordance in unprotected sex reporting among African HIV serodiscordant couples. Abstract MOPEC402.
  45. Pilcher C, Hatano H, Dasgupta A, Jones D, Torres S, Calderon F, Ospina-Norvell C, Hartogensis W, Demicco E, Geng E, Gandhi M, Havlir D. Providing same day, observed ART to newly diagnosed HIV+ outpatients is associated with improved virologic suppression. Abstract WEAD0105 LB. Video: https://youtu.be/c-yxSnPRDoo.
  46. Pohl KM, Nichols N, Chu W, Esmaeili-Firidouni P, Javitz H, Valcour V. iMap: creating maps from longitudinal MR brain images of aging HIV population to drive HAND characterization. Abstract WEPEB323.
  47. Scully E, Lockhart A, Garcia Beltran W, Bodair A, Rouyez M-C, Benichou S, Kuritzkes D, Altfeld M. Nef inhibition for enhanced NK cell killing of cells expressing reactivated HIV-1. Abstract TUPEA094.
  48. Siedner M, Kim J-H, Haberer J, Martin J, Tsai A, Boum Y, Hunt P, Bangsberg D. HIV infection and vascular stiffness among older-adults taking antiretroviral therapy in rural Uganda. Abstract WEPEB338.
  49. Solomon MM, Schechter M, Liu AY, McMahan V, Guanira JV, Hance RJ, Chariyalertsak S, Mayer KH, Grant RM; iPrEx Study Team. The safety of HIV pre-exposure prophylaxis in the presence of hepatitis B infection. Abstract TUAC0201.
  50. Ssemmondo E, Mwangwa F, Kironde J, Kwarisiima D, Clark T, Charlebois E, Kamya M, Havlir D, Chamie G. Population-based, active TB case finding during large-scale, mobile HIV testing campaigns in rural Uganda. Abstract MOPEB162.
  51. Steward WT, Sumitani J, Morris J, Ratlhagana M-J, Moran ME, Grignon J, Barnhart S, Tumbo J, Gilvydis J, Lippman SA. Peer navigation in South Africa: addressing stigma and psychosocial barriers to engagement in HIV services. Abstract TUPED781.
  52. Tiberio J, Ngonyani A, Laurent YI, Msami A, Makumbuli M, Mwankemwa S, Ndayongeje J, Matiko E, Welty S, Morris M. Characteristics of drug use in coastal and mainland Tanzania: a mixed methods, rapid assessment in 12 regions. Abstract TUPEC541.
  53. Treves-Kagan S, El Ayadi A, Pettifor A, MacPhail C, Twine R, Maman S, Kahn K, Lippman SA. Gender differences in HIV testing behaviors by community-level and individual-level stigma in rural South Africa. Abstract TUPDD0101.
  54. Treves-Kagan S, Steward W, Ntswane L, Haller R, Gilvydis J, Gulati H, Barnhart S, Lippman SA. Stigma fears undermine the scale up of HIV care and prevention in North West Province, South Africa. Abstract WEPED857.
  55. Truong H-HM, Chen Y-H, Grasso M, Robertson T, Tao L, Curotto A, McFarland W, Grant RM, Fatch R, Raymond HF, Steward WT. Risky sexual practices in casual partnerships while traveling internationally. Abstract WEPEC626.
  56. Wallace M, Bekker L-G, Roux S, Atujuna M, Sebastian E, Dye B, Elharrar V, Grant R, Amico R. HPTN 067 ADAPT: ‘PrEP Ubuntu’ and experiences with open-label PrEP among South African women. Abstract TUPEC515.
  57. Wanga I, Abuogi L, Akama E, Bukusi EA, Helova A, Musoke P, Nalwa W, Odeny T, Turan JM, Onono M. Acceptability of community-based mentor mothers among HIV-positive pregnant women and partners in the context of Option B plus in Kenya. Abstract WEPED864.
  58. Webb GM, Chew GM, Fujita T, Burwitz BJ, Wu HL, Reed JS, Hammond KB, Hansen SG, Maurer M, Korman AJ, Ndhlovu LC, Sacha JB. The negative checkpoint receptor TIGIT marks exhausted T cells during SIV infection and correlates with SIV disease progression. Abstract TUPDA0106LB.
  59. Webb K, Chitiyo V, Ndoro T, Nesara P, Zizhou S, Mahachi N, Engelsmann B, Geng E. A population-based estimate of documented completion of early infant diagnosis in Mashonaland East Province, Zimbabwe. Abstract MOPED747.
  60. Weiser S, Bukusi E, Steinfeld R, Frongillo E, Weke E, Dworkin S, Pusateri K, Shiboski S, Scow K, Butler L, Cohen C. The impact of a multisectoral agricultural and finance intervention on nutritional and HIV health outcomes in rural Kenya. Abstract MOPEC482.